Sung, H. et al. World most cancers statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 nations. CA Most cancers J. Clin. 71, 209–249 (2021).
Kakeji, Y. et al. A retrospective 5-year survival evaluation of surgically resected gastric most cancers instances from the Japanese gastric most cancers affiliation nationwide registry (2001–2013). Gastric Most cancers 25, 1082–1093 (2022).
Thrift, A. P. & El-Serag, H. B. Burden of gastric most cancers. Clin. Gastroenterol. Hepatol. 18, 534–542 (2020).
Ajani, J. A. et al. Gastric most cancers, version2.2022, NCCN scientific apply pointers in oncology. J. Natl. Compr. Most cancers Netw. 20, 167–192 (2022).
Lordick, F. et al. Gastric most cancers: ESMO scientific apply guideline for analysis, therapy and follow-up. Ann. Oncol. 33, 1005–1020 (2022).
Wang, F.-H. et al. The Chinese language Society of Medical Oncology (CSCO): Medical pointers for the analysis and therapy of gastric most cancers, 2021. Most cancers Commun. 41, 747–795 (2021).
Diakos, C. I., Charles, Ok. A., McMillan, D. C. & Clarke, S. J. Most cancers-related irritation and therapy effectiveness. Lancet Oncol. 15, e493–e503 (2014).
Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, irritation, and most cancers. Cell 140, 883–899 (2010).
Maiorino, L., Daßler-Plenker, J., Solar, L. & Egeblad, M. Innate immunity and most cancers pathophysiology. Annu. Rev. Pathol. 17, 425–457 (2022).
Hibino, S. et al. Irritation-induced tumorigenesis and metastasis. Int. J. Mol. Sci. 22, 5421 (2021).
de Martel, C., Georges, D., Bray, F., Ferlay, J. & Clifford, G. M. World burden of most cancers attributable to infections in 2018: A worldwide incidence evaluation. Lancet Glob. Well being 8, e180–e190 (2020).
Chen, J., Hong, D., Zhai, Y. & Shen, P. Meta-analysis of associations between neutrophil-to-lymphocyte ratio and prognosis of gastric most cancers. World J. Surg. Oncol. 13, 1–9 (2015).
Zhang, X. et al. Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric most cancers: An up to date meta-analysis. World J. Surg. Oncol. 18, 1–12 (2020).
Zhang, L.-X., Wei, Z.-J., Xu, A.-M. & Zang, J. H. Can the neutrophil-lymphocyte ratio and platelet-lymphocyte ratio be helpful in predicting lymph node metastasis and promising prognostic markers of gastric most cancers sufferers? Tumor maker retrospective examine. Int. J. Surg. 56, 320–327 (2018).
Ma, J. Y. & Liu, Q. Clinicopathological and prognostic significance of lymphocyte to monocyte ratio in sufferers with gastric most cancers: A meta-analysis. Int. J. Surg. 50, 67–71 (2018).
Zhang, J. et al. Single and mixed use of the platelet-lymphocyte ratio, neutrophil-lymphocyte ratio, and systemic immune-inflammation index in gastric most cancers analysis. Entrance. Oncol. 13, 1143154 (2023).
Templeton, A. J., Mcnamara, M. G., Seruga, B., Vera-Badillo, F. E. & Amir, E. Prognostic function of neutrophil-to-lymphocyte ratio in stable tumors: A scientific assessment and meta-analysis. JNCI J. Natl. Most cancers Inst. 106, dju124 (2014).
Ethier, J.-L., Desautels, D., Templeton, A., Shah, P. S. & Amir, E. Prognostic function of neutrophil-to-lymphocyte ratio in breast most cancers: A scientific assessment and meta-analysis. Breast Most cancers Res. 19, 1–13 (2017).
Shui, Y. et al. Prognostic and clinicopathological significance of systemic immune-inflammation index in pancreatic most cancers: A meta-analysis of two,365 sufferers. Ageing 13, 20585 (2021).
Muscaritoli, M. et al. Prevalence of malnutrition in sufferers at first medical oncology go to: The PreMiO examine. Oncotarget 8, 79884 (2017).
Yang, Y. et al. The prognostic dietary index is a predictive indicator of prognosis and postoperative issues in gastric most cancers: A meta-analysis. Eur. J. Surg. Oncol. 42, 1176–1182 (2016).
Nogueiro, J. et al. The affect of the prognostic dietary index (PNI) in gastric most cancers. Langenbecks Arch. Surg. 407, 2703–2714 (2022).
Xue, Y., Zhou, X., Xue, L., Zhou, R. & Luo, J. The function of pretreatment prognostic dietary index in esophageal most cancers: A meta-analysis. J. Cell. Physiol. 234, 19655–19662 (2019).
Li, J. H. et al. Preoperative albumin-to-globulin ratio and prognostic dietary index predict the prognosis of colorectal most cancers: A retrospective examine. Sci. Rep. 13, 17272 (2023).
Niu, Z. & Yan, B. Prognostic and clinicopathological impact of the prognostic dietary index (PNI) in sufferers with cervical most cancers: A meta-analysis. Ann. Med. 55, 2288705 (2023).
Dai, M. & Solar, Q. Prognostic and clinicopathological significance of prognostic dietary index (PNI) in sufferers with oral most cancers: A meta-analysis. Ageing 15, 1615 (2023).
Lehmann, Ok. et al. 18FDG-PET-CT improves specificity of preoperative lymph-node staging in sufferers with intestinal however not diffuse-type esophagogastric adenocarcinoma. Eur. J. Surg. Oncol. 43, 196–202 (2017).
Zeng, C. D. D. et al. Preoperative folate receptor-positive circulating tumor cells are related to occult peritoneal metastasis and early recurrence in gastric most cancers sufferers: A potential cohort examine. Entrance. Oncol. 12, 769203 (2022).
Pu, W. Y. et al. Prediction of most cancers development in a bunch of 73 gastric most cancers sufferers by circulating cell-free DNA. BMC Most cancers 16, 943 (2016).
Ma, S. et al. Medical utility and detection strategies of liquid biopsy in gastric most cancers. Mol. Most cancers 22, 7 (2023).
Nakata, B. et al. Serum CA 125 stage as a predictor of peritoneal dissemination in sufferers with gastric carcinoma. Most cancers Interdiscip. Int. J. Am. Most cancers Soc. 83, 2488–2492 (1998).
Li, X., Li, S., Zhang, Z. & Huang, D. Affiliation of a number of tumor markers with newly identified gastric most cancers sufferers: A retrospective examine. PeerJ 10, e13488 (2022).
Kochi, M. et al. Analysis of serum CEA and CA19-9 ranges as prognostic components in sufferers with gastric most cancers. Gastric Most cancers 3, 177–186 (2000).
Wojtukiewicz, M. Z., Hempel, D., Sierko, E., Tucker, S. C. & Honn, Ok. V. Thrombin-unique coagulation system protein with multifaceted impacts on most cancers and metastasis. Most cancers Metastasis Rev. 35, 213–33 (2016).
Falanga, A., Marchetti, M. & Vignoli, A. Coagulation and most cancers: Organic and scientific elements. J. Thromb. Haemost. 11, 223–233 (2013).
Zhang, X. et al. d-dimer, a predictor of unhealthy consequence in gastric most cancers sufferers present process radical resection. Sci. Rep. 12, 16432 (2022).
Dongmei, D. et al. d-dimer: Not simply an indicator of venous thrombosis however a predictor of asymptomatic hematogenous metastasis in gastric most cancers sufferers. PLoS ONE 9, e101125 (2014).
Liu, L. et al. Elevated plasma d-dimer ranges correlate with long run survival of gastric most cancers sufferers. PLoS ONE 9, e90547 (2014).
Ravasco, P. Diet in most cancers sufferers. J. Clin. Med. 8, 1211 (2019).
Matsui, R., Rifu, Ok., Watanabe, J., Inaki, N. & Fukunaga, T. Impression of malnutrition as outlined by the glim standards on therapy outcomes in sufferers with most cancers: A scientific assessment and meta-analysis. Clin. Nutr. 42(5), 615–624 (2023).
Zheng, H.-L. et al. Results of preoperative malnutrition on short- and long-term outcomes of sufferers with gastric most cancers: Can we do higher?. Ann. Surg. Oncol. 24, 3376–3385 (2017).
Morgan, T. M. et al. Preoperative dietary standing is a crucial predictor of survival in sufferers present process surgical procedure for renal cell carcinoma. Eur. Urol. 59, 923–928 (2011).
Baracos, V. E., Martin, L., Korc, M., Guttridge, D. C. & Fearon, Ok. C. Most cancers-associated cachexia. Nat. Rev. Dis. Primers 4, 1–18 (2018).
Solar, Ok., Chen, S., Xu, J., Li, G. & He, Y. The prognostic significance of the prognostic dietary index in most cancers: A scientific assessment and meta-analysis. J. Most cancers Res. Clin. Oncol. 140, 1537–1549 (2014).
Garner, H. & de Visser, Ok. E. Immune crosstalk in most cancers development and metastatic unfold: A posh dialog. Nat. Rev. Immunol. 20, 483–497 (2020).
Nakayama, Y. et al. Usefulness of the neutrophil/lymphocyte ratio measured preoperatively as a predictor of peritoneal metastasis in sufferers with superior gastric most cancers. Surg. Immediately 44, 2146–2152 (2014).
Kim, E. Y. & Tune, Ok. Y. The preoperative and the postoperative neutrophil-to-lymphocyte ratios each predict prognosis in gastric most cancers sufferers. World J. Surg. Oncol. 18, 1–8 (2020).
Wang, H. et al. Prognostic worth of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and mixed neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in stage iv superior gastric most cancers. Entrance. Oncol. 10, 841 (2020).
Zhang, X. et al. Predictive worth of neutrophil-to-lymphocyte ratio for distant metastasis in gastric most cancers sufferers. Sci. Rep. 12, 10269 (2022).
